131 related articles for article (PubMed ID: 22496403)
1. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus.
Guzel S; Seven A; Kocaoglu A; Ilk B; Guzel EC; Saracoglu GV; Celebi A
Diab Vasc Dis Res; 2013 Jan; 10(1):25-31. PubMed ID: 22496403
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.
Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B
J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328
[TBL] [Abstract][Full Text] [Related]
3. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin concentrations in patients with suspected reversible myocardial ischemia: observations from the Akershus Cardiac Examination (ACE) 1 Study.
Røysland R; Røsjø H; Høiseth AD; Gullestad L; Badr P; Kravdal G; Omland T
Cytokine; 2015 May; 73(1):122-7. PubMed ID: 25748834
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
Ahmed S; Sobh R
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.
Avignon A; Sultan A; Piot C; Elaerts S; Cristol JP; Dupuy AM
Diabetes Care; 2005 Sep; 28(9):2176-80. PubMed ID: 16123486
[TBL] [Abstract][Full Text] [Related]
7. Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk.
Davenport C; Ashley DT; O'Sullivan EP; Corley BT; Fitzgerald P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
J Hypertens; 2011 Dec; 29(12):2469-75. PubMed ID: 21970938
[TBL] [Abstract][Full Text] [Related]
8. Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia.
Guang-da X; Hui-ling S; Jie H
Clin Endocrinol (Oxf); 2008 Nov; 69(5):799-803. PubMed ID: 18410551
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes.
Altinova AE; Toruner F; Akturk M; Bukan N; Yetkin I; Cakir N; Arslan M
Scand J Clin Lab Invest; 2011 Jul; 71(4):340-3. PubMed ID: 21486111
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
Tavintharan S; Pek LT; Liu JJ; Ng XW; Yeoh LY; Su Chi L; Chee Fang S
Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
[TBL] [Abstract][Full Text] [Related]
11. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.
Avignon A; Sultan A; Piot C; Mariano-Goulart D; Thuan Dit Dieudonné JF; Cristol JP; Dupuy AM
Diabetes Care; 2007 Nov; 30(11):2934-9. PubMed ID: 17712025
[TBL] [Abstract][Full Text] [Related]
13. Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.
Poulsen MK; Nybo M; Dahl J; Hosbond S; Poulsen TS; Johansen A; Høilund-Carlsen PF; Beck-Nielsen H; Rasmussen LM; Henriksen JE
Cardiovasc Diabetol; 2011 Aug; 10():76. PubMed ID: 21838881
[TBL] [Abstract][Full Text] [Related]
14. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
[TBL] [Abstract][Full Text] [Related]
15. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
Grauslund J; Rasmussen LM; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes.
O'Sullivan EP; Ashley DT; Davenport C; Devlin N; Crowley R; Agha A; Thompson CJ; O'Gorman D; Smith D
Diabetes Metab Res Rev; 2010 Sep; 26(6):496-502. PubMed ID: 20809534
[TBL] [Abstract][Full Text] [Related]
17. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
[TBL] [Abstract][Full Text] [Related]
18. The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients.
Cosson E; Nguyen MT; Chanu B; Balta S; Takbou K; Valensi P
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):557-65. PubMed ID: 22502874
[TBL] [Abstract][Full Text] [Related]
19. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
[TBL] [Abstract][Full Text] [Related]
20. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.
Kim SM; Lee J; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Clin Endocrinol (Oxf); 2005 Nov; 63(5):594-8. PubMed ID: 16268814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
